ZEPTIDE 2.5MG PREFILLED SYRINGE by FEROZSONS contains Tirzepatide, a prescription injectable medicine that works through two incretin hormone pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).
Tirzepatide helps influence blood-glucose regulation, appetite, food intake, and gastric emptying. Depending on the approved indication, it may be prescribed for type 2 diabetes management and/or chronic weight management in appropriate patients.
The 2.5MG strength is generally used as the starting dose for Tirzepatide treatment. It is typically administered once weekly for the initial treatment period before the dose is increased according to the patient's response and tolerability.
❄️ TEMPERATURE-SENSITIVE PRODUCT: ZEPTIDE 2.5MG PREFILLED SYRINGE requires appropriate storage and temperature-controlled transportation. This product is currently deliverable only in Lahore.
✔️ Starting Strength of Tirzepatide – 2.5MG is generally used as the initial dose to help patients gradually adjust to Tirzepatide treatment.
✔️ Supports Weight Management – Tirzepatide can help reduce appetite and food intake, supporting weight management alongside a healthy diet and physical activity.
✔️ Helps Improve Blood Sugar Control – Tirzepatide supports glucose-dependent insulin secretion and blood-glucose regulation in appropriate adults with type 2 diabetes.
✔️ Dual GIP + GLP-1 Action – Works through both GIP and GLP-1 receptor pathways.
✔️ Helps Regulate Appetite – Tirzepatide can influence appetite-related pathways and calorie intake.
✔️ Supports Feelings of Fullness – Its effects on appetite and gastric emptying can contribute to satiety.
✔️ Once-Weekly Administration – Tirzepatide is generally administered once weekly.
✔️ Gradual Dose Introduction – The lower 2.5MG strength is designed to begin treatment before progressing to higher doses when appropriate.
🌟 Contains Tirzepatide – A dual GIP/GLP-1 receptor agonist used in appropriate patients for metabolic treatment.
💉 Prefilled Syringe Format – Convenient injectable format for prescribed subcutaneous administration.
📈 Starting Dose – 2.5MG is generally the initial Tirzepatide dose used before gradual dose escalation.
⚖️ Weight Management Support – May help reduce appetite and food intake as part of a medically supervised treatment plan.
🩸 Blood Glucose Support – May help improve glycemic control in appropriate adults with type 2 diabetes.
🏭 FEROZSONS – ZEPTIDE is supplied under the FEROZSONS brand.
📦 1 Unit Per Pack – Contains 1 prefilled syringe.
❄️ Temperature Sensitive – Requires appropriate storage and careful transportation.
🚚 Lahore Delivery Only – Currently available for delivery only in Lahore.
✔️ Use ZEPTIDE exactly as prescribed by your healthcare professional.
✔️ The usual starting dose of Tirzepatide is 2.5MG once weekly.
✔️ The 2.5MG dose is generally used for the first four weeks of treatment.
✔️ After the initial period, your doctor may increase the dose to 5MG once weekly, depending on treatment response and tolerability.
✔️ Administer the injection subcutaneously according to the manufacturer's instructions.
✔️ Common injection sites include the abdomen, thigh, or upper arm.
✔️ Rotate injection sites regularly.
✔️ Tirzepatide can generally be administered with or without food.
⚠️ Do not increase the dose without your doctor's advice.
⚠️ Do not share the prefilled syringe with another person.
Tirzepatide treatment is generally started at a low dose and gradually increased.
A commonly used dose-escalation pathway is:
2.5MG → 5MG → 7.5MG → 10MG → 12.5MG → 15MG
Weeks 1–4: 2.5MG once weekly
After Week 4: Usually increased to 5MG once weekly, if appropriate
Further dose increases may generally be made in 2.5MG increments after at least four weeks on the current dose, depending on treatment response and tolerability.
⚠️ The 2.5MG dose is primarily a treatment initiation dose and is not generally considered a maintenance dose.
Tirzepatide is a dual GIP and GLP-1 receptor agonist.
GIP activation contributes to glucose-dependent insulin secretion and influences metabolic pathways involved in energy balance.
GLP-1 activation contributes to blood-glucose regulation, appetite control, and delayed gastric emptying.
Tirzepatide influences:
✔️ Blood-glucose regulation
✔️ Insulin response
✔️ Appetite
✔️ Food intake
✔️ Gastric emptying
✔️ Feelings of fullness
✔️ Body-weight management
ZEPTIDE 2.5MG PREFILLED SYRINGE contains Tirzepatide and is generally used as the initial dose when beginning Tirzepatide therapy.
It may be prescribed as part of treatment for:
✔️ Type 2 diabetes management
✔️ Chronic weight management, depending on the approved indication
✔️ Supporting blood-glucose regulation
✔️ Supporting appetite and calorie-intake management
✔️ Beginning a gradual Tirzepatide dose-escalation program
✔️ Supporting metabolic health alongside appropriate lifestyle measures
⚠️ Tirzepatide is not a treatment for type 1 diabetes and should not replace insulin when insulin therapy is required.
🚨 Prescription Medicine: Use ZEPTIDE only under the supervision of a qualified healthcare professional.
🚨 Thyroid C-Cell Tumors: Tirzepatide carries a warning based on thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2, according to applicable prescribing information.
🚨 Pancreatitis: Seek medical attention if severe or persistent abdominal pain occurs, particularly if it radiates toward the back.
🚨 Hypoglycemia: The risk of low blood sugar may increase when Tirzepatide is used with insulin or certain insulin-releasing medicines.
🚨 Gastrointestinal Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, and indigestion may occur.
🚨 Dehydration: Significant vomiting or diarrhea may cause dehydration and potentially affect kidney function.
🚨 Gallbladder Problems: Tirzepatide may be associated with gallbladder-related adverse effects.
🚨 Pregnancy: Discuss pregnancy planning with your healthcare professional. Tirzepatide should not be used for weight reduction during pregnancy.
🚨 Oral Medicines: Tirzepatide delays gastric emptying and may affect absorption of certain oral medicines.
Possible side effects include:
✔️ Nausea
✔️ Diarrhea
✔️ Decreased appetite
✔️ Vomiting
✔️ Constipation
✔️ Abdominal discomfort
✔️ Indigestion
✔️ Injection-site reactions
✔️ Fatigue
✔️ Belching
✔️ Acid reflux
Gastrointestinal effects can occur particularly when starting treatment or increasing the dose.
🚨 Severe or persistent abdominal pain
🚨 Persistent vomiting or severe dehydration
🚨 Difficulty breathing or signs of a serious allergic reaction
🚨 Symptoms of severe hypoglycemia
🚨 Yellowing of the skin or eyes
🚨 Severe or persistent gastrointestinal symptoms
ZEPTIDE 2.5MG PREFILLED SYRINGE is a temperature-sensitive injectable medicine.
❄️ Store according to the manufacturer's recommended storage conditions.
🚫 Do not freeze the product.
🚫 Do not use the product if it has been frozen or exposed to inappropriate temperatures.
☀️ Protect the medicine from excessive heat and direct sunlight.
📦 Appropriate temperature-controlled handling is important during transportation.
🚚 Delivery: ZEPTIDE 2.5MG PREFILLED SYRINGE is currently available for delivery only in Lahore.
⭐⭐⭐⭐⭐ “I ordered ZEPTIDE 2.5MG from SuperCare Pharma and the ordering process was very smooth. The product was securely packed and delivered safely in Lahore.”
— Ahmed K., Lahore 📍
⭐⭐⭐⭐⭐ “Very satisfied with the service. The temperature-sensitive medicine was handled carefully and the delivery was professional.”
— Usman R., Lahore 📍
⭐⭐⭐⭐⭐ “The order was easy to place and arrived properly packed. Excellent experience with SuperCare Pharma.”
— Hassan M., Lahore 📍
ZEPTIDE 2.5MG PREFILLED SYRINGE by FEROZSONS provides Tirzepatide 2.5MG in a convenient prefilled syringe format.
The 2.5MG strength is generally used as the starting dose of Tirzepatide, allowing the body to gradually adjust before treatment is increased to higher strengths when clinically appropriate.
Tirzepatide works through GIP and GLP-1 receptor pathways, influencing important metabolic processes associated with blood-glucose regulation, appetite, food intake, gastric emptying, and body-weight management.
❄️ Temperature Sensitive | Lahore Delivery Only
⚠️ Prescription medicine – use only under the supervision of a qualified healthcare professional.
✔️ ZEPTIDE contains Tirzepatide and is generally used as the starting dose when beginning Tirzepatide treatment. Depending on the approved indication, Tirzepatide may be prescribed for type 2 diabetes management and/or chronic weight management.
✔️ Yes. 2.5MG once weekly is generally the recommended starting dose for Tirzepatide, typically used for the first four weeks before increasing the dose as prescribed.
✔️ Tirzepatide 2.5MG is generally administered once weekly. Follow your doctor's instructions regarding the specific day and duration.
✔️ Common side effects may include nausea, diarrhea, decreased appetite, vomiting, constipation, abdominal discomfort, and indigestion.
📢 ZEPTIDE 2.5MG PREFILLED SYRINGE by FEROZSONS is available through SuperCare Pharma, with temperature-sensitive delivery currently available only in Lahore.
🏆 Trusted Online Pharmacy in Pakistan – Convenient online access to medicines and healthcare products.
💊 Genuine Pharmaceutical Products – Quality medicines from established pharmaceutical brands.
❄️ Temperature-Sensitive Handling – Special care for temperature-sensitive injectable products.
📦 Secure Packaging – Products are carefully prepared for transportation.
🚚 Lahore Delivery – ZEPTIDE 2.5MG is currently available for delivery in Lahore.
💰 Competitive Prices – Convenient online shopping at competitive prices.
📞 Customer Support – Assistance for product and delivery queries.
Looking for ZEPTIDE 2.5MG PREFILLED SYRINGE (Tirzepatide)?
Order ZEPTIDE 2.5MG by FEROZSONS from SuperCare Pharma for convenient online ordering and temperature-sensitive delivery in Lahore.
💙 ZEPTIDE 2.5MG | Tirzepatide | FEROZSONS | Prefilled Syringe
❄️ Temperature Sensitive | Lahore Delivery Only
⚠️ Prescription medicine – use only under the supervision of a qualified healthcare professional.
